XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.18

-0.3%

Nov 28 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (16482)	11/23/2003 5:39:57 PM
From: Robert K.	Read Replies (1) of 17367

George. The company thinks it is even possible that the dose in the meningo trial was too low. But the bottom line remains >amongst those that survived to get the full bpi dose > that WAS statitical. Not even to mention all that died before they got ANY dose. Lastly the request for "additional data" was never met and whatever that type of data was is still a state secret. It could be another trial, it could be somethng lame like endotoxin levels, or even maybe time on a ventilator.......... Have you bought in yet? I know you are thinking.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next